Clinical Trial Update: A RCT COMPARING LACTULOSE AND RIFAXIMIN ASSOCIATED WITH A VEGETABLE DIET IN THE PREVENTION OF POST-TIPS OVERT HEPATIC ENCEPHALOPATHY [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 randomized trial comparing lactulose and rifaximin (with a vegetable diet) to prevent post-TIPS hepatic encephalopathy in cirrhotic patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis
• Hepatic Encephalopathy

Drugs mentioned

• LACTULOSE (Lactulose)
• Rifaximin (rifaximin)

Snippet

Sponsor: University of Roma La Sapienza | Conditions: Cirrhotic Patients Undergoing TIPS Placement | Phase 1, Phase 2 | Status: UNKNOWN